Express News | HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target
Express News | Metagenomi Technologies LLC : Jefferies Cuts Target Price to $21 From $22
Express News | Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
Express News | Metagenomi Inc: Cash Runway Anticipated to Support Anticipated Operating Plans Into 2027
Metagenomi Technologies, LLC | 10-Q: Quarterly report
Press Release: Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational develo
Metagenomi Price Target Announced at $10.00/Share by HC Wainwright & Co.
Metagenomi Price Target Announced at $10.00/Share by HC Wainwright & Co.
Express News | Metagenomi, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the consensus estimate loss of $(3.55).The company reported sales of $167
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out
Express News | Metagenomi Shares Are Trading Lower After Moderna and the Company Mutually Agreed to Terminate Their Collaboration on Primary Hyperoxaluria Type 1 and Rights to Develop the PH1 Program. Also, JP Morgan Downgraded the Stock From Overweight to Neutral and L
Metagenomi Cut to Neutral From Overweight by JP Morgan
Metagenomi Cut to Neutral From Overweight by JP Morgan
Express News | JP Morgan Downgrades Metagenomi to Neutral, Lowers Price Target to $6
Express News | Metagenomi Inc : Chardan Capital Markets Cuts Target Price to $17 From $21
Express News | Metagenomi Inc : JP Morgan Cuts Target Price to $6 From $16
Express News | Metagenomi Inc : JP Morgan Cuts to Neutral From Overweight
Metagenomi, Moderna Terminate Gene Editing Collaboration
Express News | Metagenomi Inc: Expects to Report That It Had About $327.4 Mln in Cash & Cash Equivalents as of March 31, 2024
Express News | Metagenomi: Under Termination Deal, Regained Full Development, Commercialization Rights to Wholly-Owned Base Editing, Rna-Mediated Integration Systems
Express News | Metagenomi Inc: On April 26, Co and Modernatx, Inc Mutually Terminated Strategic Collaboration and License Agreement Dated Oct 29, 2021
No Data